Depression in dermatological patients identified by the Mini International Neuropsychiatric Interview questionnaire - 09/08/11
, Andr’e Ofek–Shlomai, MD a, b, Daniel A. Vardy, MD a, b, Zeev Weiner, MD b, c, Pesach Shvartzman, MD a, b
Correspondence to: Arnon D. Cohen, MD, MPH, Director, Dermatology Service, Southern District, Clalit Health Services, POB 1076, Omer 84965, Israel.Beer-Sheva and Tel Aviv, Israel
Abstract |
Background |
Early diagnosis and treatment of depression are of vital importance in dermatological patients.
Objective |
Our purpose was to evaluate the prevalence of depression among patients visiting a dermatology clinic in southern Israel.
Methods |
Patients who visited the dermatology clinic were interviewed using the Mini International Neuropsychiatric Interview screening tool.
Results |
The study included 384 patients. The screening questionnaire identified 37 patients (9.6%) with major depression, 3 patients (0.8%) with minor depression, and 74 patients (19.3%) with depressive symptoms. Higher prevalence of depression was found among widowers, among divorced or separated patients, and in unemployed patients. Depression was significantly associated with the perception of severity and suffering induced by the skin diseases.
Limitations |
The study was conducted in a cross-sectional design. To confirm causality, a longitudinal study should be conducted.
Conclusion |
Depression should be a consideration by dermatologists in the effective management of skin diseases.
Le texte complet de cet article est disponible en PDF.Plan
| Funding sources: None. Conflicts of interest: None identified. Reprints not available from the authors. |
Vol 54 - N° 1
P. 94-99 - janvier 2006 Retour au numéro
Article précédent
- Protection from visible light by commonly used textiles is not predicted by ultraviolet protection
- Caroline Van den Keybus, Jan Laperre, Rik Roelandts
- Videocapillaroscopic alterations in erythematotelangiectatic rosacea
- Paolo Rosina, Maria Rosa Zamperetti, Andrea Giovannini, Carlo Chieregato, Giampiero Girolomoni
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?